| License: Creative Commons Attribution Non-commercial No Derivatives 4.0 PDF - Published Version Early View (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-508412
- DOI to cite this document:
- 10.5283/epub.50841
Abstract
A distinct group of colorectal carcinomas (CRCs) referred to as the “CpG island methylator phenotype” (CIMP) shows an extremely high incidence of de novo DNA methylation and may share common pathological, clinical or molecular features. However, there is limited consensus about which CpG islands (CGIs) define a CIMP, particularly in microsatellite stable (MSS) carcinomas. To study this phenotype ...

Owner only: item control page